Search research articles
Contact Us
Filters
Showing results (41-50 of 261) with videos related to
Page
of 27
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
October 1, 1990
Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
H Namba, S A Rubin, J A Fagin
The Journal of Clinical Endocrinology and Metabolism
|
June 19, 2013
Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression
Ronald A Ghossein, Nora Katabi, James A Fagin
Endocrinology
|
November 1, 1989
Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone
J A Fagin, C Fernandez-Mejia, S Melmed
Diabetes
|
December 1, 1987
Insulinotropic effects of vanadate
J A Fagin, K Ikejiri, S R Levin
Lancet (London, England)
|
September 17, 1983
Economic realities of home blood glucose monitoring
J A Fagin, L Litwak, R A Gutman
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1991
Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms
K Matsuo, S H Tang, J A Fagin
Arquivos Brasileiros De Endocrinologia E Metabologia
|
September 25, 2007
[Thyroid cancer: past, present and future]
James A Fagin, Laura S Ward, Edna T Kimura
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2010
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer
James A Fagin, R Michael Tuttle, David G Pfister
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1986
Expression of the myc cellular proto-oncogene in human thyroid tissue
S Yamashita, J Ong, J A Fagin, et al.
Oncogene
|
July 11, 2003
RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase
Jeffrey A Knauf, Hiroaki Kuroda, Saswata Basu, et al.
Page
of 27
Search research articles
Search
Showing results (41-50 of 261) with videos related to
Sort By:
Page
of 27
Molecular Endocrinology (Baltimore, Md.)
|
October 1, 1990
Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
H Namba, S A Rubin, J A Fagin
The Journal of Clinical Endocrinology and Metabolism
|
June 19, 2013
Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression
Ronald A Ghossein, Nora Katabi, James A Fagin
Endocrinology
|
November 1, 1989
Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone
J A Fagin, C Fernandez-Mejia, S Melmed
Diabetes
|
December 1, 1987
Insulinotropic effects of vanadate
J A Fagin, K Ikejiri, S R Levin
Lancet (London, England)
|
September 17, 1983
Economic realities of home blood glucose monitoring
J A Fagin, L Litwak, R A Gutman
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1991
Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms
K Matsuo, S H Tang, J A Fagin
Arquivos Brasileiros De Endocrinologia E Metabologia
|
September 25, 2007
[Thyroid cancer: past, present and future]
James A Fagin, Laura S Ward, Edna T Kimura
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2010
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer
James A Fagin, R Michael Tuttle, David G Pfister
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1986
Expression of the myc cellular proto-oncogene in human thyroid tissue
S Yamashita, J Ong, J A Fagin, et al.
Oncogene
|
July 11, 2003
RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase
Jeffrey A Knauf, Hiroaki Kuroda, Saswata Basu, et al.
Page
of 27